Latest Conference Articles

New treatments are desperately needed for neuroendocrine tumors, said Leonard Saltz, MD, Memorial Sloan-Kettering Cancer Center.

George Somlo, MD, City of Hope Comprehensive Cancer Center, presented the updates to the NCCN Multiple Myeloma Guidelines.

These new guidelines were presented by Lee M. Krug, MD, Memorial Sloan-Kettering Cancer Center.

The escalating costs of cancer care combined with variations in concordance with evidence-based practice guidelines is could collapse the US Healthcare System.

At NCCN, Richard Klausner, MD, gave a spirited presentation on "New Advances in Molecular Diagnostics and Cancer."

Genetic testing as part of initial management of patients on warfarin reduced hospitalizations by nearly 30%.

A novel drug-eluting stent using a new alloy and design achieved comparable outcomes versus earlier generation drug-eluting stents in the PERSEUS trial.

Remote monitoring of patients with an ICD had shorter times to clinical decision-making versus standard office visits in the CONNECT trial.

Three highly provocative papers from the Gynecologic Oncology Group were presented during the initial plenary session of SGO.

Portable ORs, using thoughts to control motions, and auto-anesthesia--these are some of the technologies that will transform the practice of cardiology.

A combination regimen of docetaxel and carboplatin prolongs PFS in recurrent ovarian cancer but decreases quality of life.

Among the top study results presented during this session at the ACC 59th Annual Scientific Session, here are three focusing on pulmonary hypertension.

During the meeting, there were hundred of poster presentations. Hypertension-specific posters are profiled here.

In yet another outstanding set of poster presentations, the following were among the best under the heading "hypertension and heart failure."

These three posters presented at the conference stood out under the "exercise and vascular modulation" heading.

A cryoablation catheter system was nearly 10 times more effective than standard drug therapy in eliminating intermittent atrial fibrillation and equally safe.

Gardasil, a vaccine that prevents cervical cancer, also reduces the likelihood of recurrence after surgery by 40%.

This year's updates parse sarcomas, emphasize the importance of accurate pathology evaluations, and examine the value of molecular testing.

NCCN included a dinner symposium on Maintenance Therapy for Non-Small Cell Lung Cancer.

Several studies were presented under the topic of biomarker implications in myocardial ischemia/infarction at the ACC.10.

There were several very good studies presented during this poster session at ACC.10. Here, the best are highlighted.

Paul F. Engstrom, MD, reviewed the recent changes to the National Comprehensive Cancer Network guidelines for colon and rectal cancer.

At NCCN, B. Douglas Smith, MD, presented updates to the NCCN Acute Myeloid Leukemia Guidelines.

At NCCN, David Ettinger, MD, presented updates to the NCCN Occult Primary Guidelines.

Rep. Paul Ryan (R-Wis.) and Chris Jennings discussed the state of health care reform.

ACC.10 workshop offers unique, visually engaging way to learn cardiac auscultation.

Patients with mitral regurgitation treated with the MitraClip valve repair system experience fewer complications compared to patients treated with surgery.

Highlights from studies on the hypertension effects on the left ventricle, from posters presented at the 59th Annual Scientific Sessions of the ACC.

Poster presentations focused on angiotensin receptor blockers from the ACC 59th Annual Scientific Session.